IT’S TIME WE LEARNT MORE

Name and business address of the holder of the certificate of registration: iNova Pharmaceuticals (Pty) Ltd. Co. Reg. No. 1952/001640/07, 15e Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za. For further information, speak to your healthcare professional. Further information is available on request from iNova Pharmaceuticals IN2553/18.

References: 1. Q&A with Dr Corne Brink (Transcript from 16 January 2018). 2. Sexually Transmitted Disease Guide – What is Bacterial Vaginosis (https://www.std-gov.org/stds/bacterial_vaginosis.htm) Website accessed on 13 March 2018. 3. Ries AJ. Treatment of Vaginal Infections: Candidiasis, Bacterial Vaginosis, and Trichomoniasis. J Am Pharm Assoc 1997; NS37:563-9. 4. Thrush and Bacterial Vaginosis. FPA (Sexual Health Charity). NHS. January 2014 (https://www.fpa.org.uk/sites/default/files/thrush-bacterial-vaginosis-information-and-advice.pdf) Website accessed on 8 February 2018. 5. Bailey E. Yeast Infection vs. Bacterial Vaginosis. Sexual Health (https://www.healthcentral.com/article/yeast-infection-vs-bacterial-vaginosis) Website accessed on 8 February 2018. 6. Chavoustie SE et al. Experts explore the state of Bacterial Vaginosis and the unmet needs facing women and providers. International Journal of Gynecology and Obstetrics. (http://onlinelibrary.wiley.com/doi/10.1002/ijgo.12114/full) Website accessed May 2017. 7. Product approved package insert 2001/02/11. 8. Hanson JM, McGregor JA, Hillier S et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med. 2000 Nov; 45(11):889-96.